Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Pentamidine | hsa00500 | Starch and sucrose metabolism | 2.15E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Pentamidine | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Pentamidine | hsa00590 | Arachidonic acid metabolism | 3.63E-02 | 2 | P11712, P18054 | CYP2C9, ALOX12 | More | | Pentamidine | hsa00591 | Linoleic acid metabolism | 3.94E-02 | 1 | P11712 | CYP2C9 | More | | Pentamidine | hsa00970 | Aminoacyl-tRNA biosynthesis | 9.57E-03 | 3 | O95363, P54136, P14868 | FARS2, RARS1, DARS | More | | Pentamidine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 8.58E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Pentamidine | hsa00982 | Drug metabolism - cytochrome P450 | 8.58E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Pentamidine | hsa04014 | Ras signaling pathway | 1.60E-02 | 4 | P49767, P17252, Q14644, P0DP23 | VEGFC, PRKCA, RASA3, CALM1 | More | | Pentamidine | hsa04020 | Calcium signaling pathway | 8.12E-05 | 6 | P17252, Q93086, Q15746, P0DP23, P23634, P49767 | PRKCA, P2RX5, MYLK, CALM1, ATP2B4, VEGFC | More | | Pentamidine | hsa04022 | cGMP-PKG signaling pathway | 3.50E-02 | 3 | P23634, Q15746, P0DP23 | ATP2B4, MYLK, CALM1 | More | | Pentamidine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.91E-02 | 6 | P09341, P25024, P25025, P47992, Q9UBD3, P01375 | CXCL1, CXCR1, CXCR2, XCL1, XCL2, TNF | More | | Pentamidine | hsa04080 | Neuroactive ligand-receptor interaction | 1.20E-02 | 8 | P08311, Q15722, Q9H228, P43657, P21462, P21730, P14416, P35318 | CTSG, LTB4R, EDG8, P2RY5, FPR1, C5AR1, DRD2, ADM | More | | Pentamidine | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.02E-02 | 3 | P0DP23, P17252, P23634 | CALM1, PRKCA, ATP2B4 | More | | Pentamidine | hsa04270 | Vascular smooth muscle contraction | 1.50E-02 | 3 | Q15746, P17252, P0DP23 | MYLK, PRKCA, CALM1 | More | | Pentamidine | hsa04510 | Focal adhesion | 2.35E-02 | 4 | Q15746, P17252, Q13489, P49767 | MYLK, PRKCA, BIRC3, VEGFC | More | | Pentamidine | hsa04610 | Complement and coagulation cascades | 3.16E-03 | 2 | P00734, P0C0L4 | F2, C4A | More | | Pentamidine | hsa04612 | Antigen processing and presentation | 5.26E-04 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Pentamidine | hsa04613 | Neutrophil extracellular trap formation | 9.93E-04 | 13 | O60603, P05164, P08246, Q9UM07, Q13547, Q92769, Q15080, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, NCF4, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Pentamidine | hsa04625 | C-type lectin receptor signaling pathway | 4.80E-02 | 6 | Q9ULY5, P20749, Q14643, P01375, Q13191, Q16539 | CLEC4E, BCL3, ITPR1, TNF, CBLB, MAPK14 | More | | Pentamidine | hsa04640 | Hematopoietic cell lineage | 2.52E-02 | 9 | P13612, P14778, P27930, P15144, P11836, P09693, P01732, P13765, P01375 | ITGA4, IL1R1, IL1R2, ANPEP, MS4A1, CD3G, CD8A, HLA-DOB, TNF | More | | Pentamidine | hsa04650 | Natural killer cell mediated cytotoxicity | 5.58E-04 | 9 | P01375, P78314, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, SH3BP2, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Pentamidine | hsa04657 | IL-17 signaling pathway | 1.77E-03 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Pentamidine | hsa04658 | Th1 and Th2 cell differentiation | 7.47E-03 | 8 | Q04759, P20963, P09693, Q16539, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, STAT4, GATA3, TBX21, HLA-DOB | More | | Pentamidine | hsa04659 | Th17 cell differentiation | 3.13E-02 | 8 | Q04759, Q16539, P13765, P14778, Q9UL17, P23771, P09693, P20963 | PRKCQ, MAPK14, HLA-DOB, IL1R1, TBX21, GATA3, CD3G, CD247 | More | | Pentamidine | hsa04660 | T cell receptor signaling pathway | 8.00E-03 | 10 | P01375, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, Q16539, P49841 | TNF, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, MAPK14, GSK3B | More | | Pentamidine | hsa04720 | Long-term potentiation | 3.63E-02 | 2 | P17252, P0DP23 | PRKCA, CALM1 | More | | Pentamidine | hsa04726 | Serotonergic synapse | 1.50E-02 | 3 | P17252, P11712, P18054 | PRKCA, CYP2C9, ALOX12 | More | | Pentamidine | hsa04750 | Inflammatory mediator regulation of TRP channels | 9.58E-03 | 3 | P18054, P17252, P0DP23 | ALOX12, PRKCA, CALM1 | More | | Pentamidine | hsa04912 | GnRH signaling pathway | 6.34E-03 | 6 | P17252, Q16539, Q9Y6R4, Q14643, P0DP23, P22694 | PRKCA, MAPK14, MAP3K4, ITPR1, CALM1, PRKACB | More | | Pentamidine | hsa04916 | Melanogenesis | 3.97E-03 | 3 | P0DP23, Q9UJU2, P17252 | CALM1, LEF1, PRKCA | More | | Pentamidine | hsa04920 | Adipocytokine signaling pathway | 4.72E-02 | 4 | P33121, Q04759, Q9Y4H2, P01375 | ACSL1, PRKCQ, IRS2, TNF | More | | Pentamidine | hsa04921 | Oxytocin signaling pathway | 2.19E-02 | 3 | Q15746, P0DP23, P17252 | MYLK, CALM1, PRKCA | More | | Pentamidine | hsa04925 | Aldosterone synthesis and secretion | 5.51E-03 | 3 | P0DP23, P17252, P23634 | CALM1, PRKCA, ATP2B4 | More | | Pentamidine | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 1.40E-02 | 2 | P23634, P17252 | ATP2B4, PRKCA | More | | Pentamidine | hsa04970 | Salivary secretion | 3.97E-03 | 3 | P23634, P17252, P0DP23 | ATP2B4, PRKCA, CALM1 | More | | Pentamidine | hsa04971 | Gastric acid secretion | 5.51E-03 | 3 | P17252, P0DP23, Q15746 | PRKCA, CALM1, MYLK | More | | Pentamidine | hsa04972 | Pancreatic secretion | 1.40E-02 | 2 | P23634, P17252 | ATP2B4, PRKCA | More | | Pentamidine | hsa04976 | Bile secretion | 3.87E-02 | 3 | O43315, P22694, P08183 | AQP9, PRKACB, ABCB1 | More | | Pentamidine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 3.87E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Pentamidine | hsa05133 | Pertussis | 1.73E-03 | 3 | P0DP23, P09871, P0C0L4 | CALM1, C1S, C4A | More | | Pentamidine | hsa05140 | Leishmaniasis | 1.69E-03 | 7 | P13612, O75015, P13765, O60603, P01375, Q16539, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MAPK14, NCF4 | More | | Pentamidine | hsa05143 | African trypanosomiasis | 4.81E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Pentamidine | hsa05144 | Malaria | 9.81E-04 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Pentamidine | hsa05146 | Amoebiasis | 2.59E-05 | 8 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Pentamidine | hsa05202 | Transcriptional misregulation in cancer | 2.41E-03 | 15 | P41732, P14780, P27930, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, Q92769, P12980, P24522 | TSPAN7, MMP9, IL1R2, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, HDAC2, LYL1, GADD45A | More | | Pentamidine | hsa05204 | Chemical carcinogenesis | 1.40E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Pentamidine | hsa05214 | Glioma | 4.55E-02 | 2 | P0DP23, P17252 | CALM1, PRKCA | More | | Pentamidine | hsa05321 | Inflammatory bowel disease | 2.22E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Pentamidine | hsa05332 | Graft-versus-host disease | 2.76E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | Pentamidine | hsa05418 | Fluid shear stress and atherosclerosis | 4.81E-02 | 6 | Q16539, P10599, P14780, P01375, P14778, P27930 | MAPK14, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |